Nama Insights

Welltower (WELL)

Real Estate · Reit Healthcare Facilities · NYSE

S&P 500
Welltower (WELL) is a Real Estate company in the Reit Healthcare Facilities industry. It has a market capitalization of $179.74B, a trailing price-to-earnings ratio of 106.1 and a free-cash-flow yield of 1.7%. Over the most recent reported fiscal year, revenue grew 35.8% and free cash flow per share grew 16.1%. Nama's AI scorecard rates it Hold, 4.7 out of 10. On 12-month momentum it ranks in the rising band of its market.
AI scorecard
Hold · 4.7/10
The sections balance. As of Nov 7, 2026.
Momentum
Rising · +17.8% over 12 months ex. last
Second-best fifth of its market on the past year's move.
Shariah screen
Shariah Compliant
Passes our debt, cash and income screen; not a scholar's ruling.
Off its high
-4.0%
How far the last close sits under the highest price of the past five years.
Market cap$179.74B
Trailing P/E106.1
Price / book3.7
Price / sales13.0
FCF yield1.7%
Dividend yield1.4%
Gross margin38.9%
Operating margin4.6%
Net margin12.2%
Revenue growth (YoY)+35.8%
Revenue growth (3-yr annual)+22.7%
EPS growth (YoY)+31.8%
FCF/share growth (YoY)+16.1%
Beta0.8
ExchangeNYSE
SectorReal Estate
IndustryReit Healthcare Facilities

WELL earnings

Next report: Feb 9, 2027 (Q4 2026, EPS estimate $0.67). Beat the EPS estimate in 1 of 4 recent quarters.

QuarterReportedEPSEstimateSurpriseRevenue
Q3 2026 Oct 26, 2026 $0.67 $0.71 -5.6% $3.69B
Q2 2026 Jul 27, 2026 $0.54 $0.65 -16.9% —
Q1 2026 Apr 28, 2026 $0.55 $0.50 +10.0% $3.31B
Q4 2025 Feb 10, 2026 $0.55 $0.59 -6.8% $3.13B

WELL analyst price target

Median target $261.50 from 22 analysts, ranging $219.00 – $292.00.

Reit Healthcare Facilities peers

TickerCompanyMarket capP/E
VTR Ventas $46.93B 164.3
OHI Omega Healthcare Investors $15.34B 17.6
DOC Healthpeak Properties $14.71B 40.5
AHR American Healthcare REIT $12.62B 103.4
CTRE CareTrust REIT $9.03B 25.1
HR Healthcare Realty Trust $6.66B —
SBRA Sabra Health Care REIT $5.51B 31.9
NHI National Health Investors $3.50B 21.1
Explore live WELL data on Nama Insights →

Recent Congressional trades

Welltower trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →

Member Chamber Trade Amount Disclosed
Alan Armstrong Senate Buy $1,001 - $15,000 Jul 21, 2026
Alan Armstrong Senate Buy $1,001 - $15,000 Jul 21, 2026
Jonathan Jackson House Buy $1,001 - $15,000 Mar 12, 2026
Jefferson Shreve House Sell $50,001 - $100,000 Jun 22, 2025
Daniel Goldman House Sell $15,001 - $50,000 Aug 13, 2023

WELL FAQ

Is WELL a buy?
Nama's AI scorecard currently rates Welltower Hold (4.7 out of 10), a call computed from its profitability, cash generation, growth, valuation and balance sheet. It is a research reading, not investment advice.
What is WELL's P/E ratio?
Welltower trades at a trailing price-to-earnings ratio of 106.1.
When does WELL report earnings?
Welltower's next scheduled report is on Feb 9, 2027. Analysts expect EPS of $0.67.
What is the WELL price target?
The median analyst price target from 22 analysts is $261.50, with a range of $219.00 – $292.00.
Is WELL Shariah compliant?
Nama's AAOIFI-style screen reads Welltower as Shariah Compliant. Passes our debt, cash and income screen; not a scholar's ruling.
Does WELL pay a dividend?
Yes — Welltower's dividend yield is 1.4%.